Myeong Jin Yoon

Cell Metabolism · 2011

A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Whom Myeong Jin Yoon trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Seon-Young Kim

Who trusts Myeong Jin Yoon overall

  1. S. Imai
  2. Jun Yoshino

Papers from Myeong Jin Yoon's perspective

Ordered by how strongly the researchers Myeong Jin Yoon trusts endorse each paper. Same corpus, a different order for every researcher.

  1. FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. (Cancer Research)
  2. Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase (EMBO Journal)
  3. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. (Developmental Cell)
  4. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. (Cell Metabolism)
  5. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle (Cell Metabolism)
  6. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes (Nature Medicine)
  7. PAGE: Parametric Analysis of Gene Set Enrichment (BMC Bioinformatics)
  8. How Obesity Causes Diabetes: Not a Tall Tale (Science)
  9. Mitochondrial Dysfunction and Type 2 Diabetes (Science)
  10. Inflammation and insulin resistance. (Journal of Clinical Investigation)

Their papers